Asthma

The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.

Latest News

Man holding paper model of lungs | Image credit: Elena - stock.adobe.com
Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control

July 3rd 2025

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.

Man having asthma attack on couch | Image credit: Pixel-Shot – stock.adobe.com
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

June 25th 2025

Health equity. | Image Credit: Djavan Rodriguez - stock.adobe.com
The Health-Related Consequences of Redlining

October 3rd 2024

Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi
Advancements in Asthma Treatment: Next Steps and Insights From Clinical Development of Rilzabrutinib

August 1st 2024

What We’re Reading: COVID-19 Vaccine and Fewer Asthma Symptoms; Cyberattack Reporting Rule; MA Misdiagnoses Drive Up Costs
What We’re Reading: COVID-19 Vaccine and Fewer Asthma Symptoms; Cyberattack Reporting Rule; MA Misdiagnoses Drive Up Costs

July 8th 2024

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo